The Diabetes Drug That Turned Out to Be a Kidney Drug
SGLT2 inhibitors were developed to lower blood sugar by making you urinate it out. The glucose effect turned out to be the least interesting thing about them, and the kidney trials changed how this complication is treated.
Jul 25, 2026







